Biolife Solutions (BLFS) Price to Earnings (2010 - 2026)

Biolife Solutions (BLFS) has reported Price to Earnings for 17 consecutive years, with 30.61 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings rose 147.04% year-over-year to 30.61 in Q2 2026; TTM through Jun 2026 was 23.83, a 112.79% increase from a year earlier, with the FY2025 full-year figure at 253.63, down 320.41% from the prior year.
• Price to Earnings was 30.61 for Q2 2026 at Biolife Solutions, down from 811.49 in the prior quarter.
• Over five years, Price to Earnings peaked at 1970.38 in Q3 2025 and troughed at 2424.12 in Q1 2025.
• A 5-year average of 42.79 and a median of 51.27 in 2023 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings tumbled 3171.27% in 2024 and jumped 389.89% in 2025, its largest moves.
• Over 5 years, Price to Earnings stood at 15.85 in 2022, then slumped by 246.08% to 54.85 in 2023, then surged by 278.2% to 97.74 in 2024, then rose by 7.72% to 105.28 in 2025, then plunged by 70.93% to 30.61 in 2026.
• The last three Price to Earnings figures came in at 30.61 (Q2 2026), 811.49 (Q1 2026), and 105.28 (Q4 2025), per Business Quant data.